Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by StrikingMoose


ATBPF

RE:7 million warrants at .31 attached to debenture

45 is a great share price at the moment. What great news. Imagine how much...

April 3, 2018

ATBPF

RE:Thoughts on Celebrex/Cardiovascular issues

Celebrex and other COX 2 selective NSAIDs primarily are the ones that cause...

April 2, 2018

ATBPF

RE:RE:RE:Imo antibe has long way to go

If you own shares in this company and don't know about a pivotal trial...

April 2, 2018

ATBPF

RE:Imo antibe has long way to go

They already proved less dose you dipshiit. They are using 15% of the...

April 2, 2018

ATBPF

RE:RE:RE:RE:RE:RE:float has increased by 25 million shares...80 mill cap here

I don't think so, looking at the O/S shares slowly increasing since...

April 2, 2018

ATBPF

RE:RE:RE:RE:float has increased by 25 million shares...80 mill cap here

Warrant holders holding from recent PP are stupid to sell now at a double...

April 2, 2018

ATBPF

RE:float has increased by 25 million shares...80 mill cap here

20 million* not 25.   That's great, at least $3 million cash in...

April 2, 2018

ATBPF

RE:RE:RE:RE:A decent answer?

People want pills lol. Many will say cannabis is the future but most people...

April 2, 2018

ATBPF

RE:RE:RE:A decent answer?

Opioid agonists**** not antagonists. I'm working on short sleep today

April 2, 2018

ATBPF

RE:RE:A decent answer?

PLXP markets their aspirin derivative as an anticoagulant not as a pain...

April 2, 2018

ATBPF

RE:Prediction

No idea. I am working on the same supposition as you though. Maybe we are...

April 1, 2018

ATBPF

RE:Yes, Watch, Learn and listen!

I don't see many people arguing about the released test results. They'...

March 31, 2018

ATBPF

Everyone have a great Easter weekend

Surprising end to the day, I was starting to get discouraged this week. Haven...

March 29, 2018

ATBPF

RE:Congrats to all those who called a sub 0.40 price - wow

Ya buddy. Can't believe the trolls were right hahaha. I'll just sit...

March 28, 2018

ATBPF

RE:if you look at tape instituions all dumping

Naproxen ulcer rates are well established. If they used small ulcer sizes to...

March 27, 2018

ATBPF

RE:RE:RE:RE:RE:RE:Also

I couldn't care less*** My pet peeve hahaha. I could care less means you...

March 26, 2018

ATBPF

RE:RE:RE:RE:RE:RE:RE:Also

With the exercising in warrants as of late along with debentures they should...

March 26, 2018

ATBPF

RE:Antibe - Potential Acquisition target

Behind a paywall

March 26, 2018

ATBPF

RE:Q4 studies 2018 - risks?

Very little if any risk when looking at the efficacy study. They've...

March 26, 2018

ATBPF

RE: Pharmas hitting a maturation point with patents: Enter ATE

I read an article about that recently. About how new drug discoveries are way...

March 25, 2018

Featured Company